leadf
logo-loader
viewPhagoMed Biopharma

PhagoMed looks to raise around $18M to scale up its bacterial infections treatment

PhagoMed Biopharma GmbH CEO Alexander Belcredi spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The Austria-based biotech's pipeline is focused on treating biofilm-forming bacterial infections, which are all in preclinical development. The company specializes in fighting multi-resistant bacteria, where multiple antibiotics have become ineffective.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Water Tower Research President talks Energy and how Capstone Turbine is key...

Water Tower Research Co-Founder and President Shawn Severson joined Steve Darling from Proactive to share some insight about the Energy sector and how it is being viewed by users. Severson also told Proactive about Capstone Turbine and some things investors need to watch for from the company...

1 hour, 27 minutes ago

2 min read